Aditi Hazra, PhD, MPH
Assistant Professor of Medicine, Harvard Medical School
Associate Epidemiologist, Brigham and Women’s Hospital
ahazra@bwh.harvard.edu
Dr. Hazra received her PhD in cancer biology from The University of Texas M.D. Anderson Cancer Center and was a post-doctoral fellow in the Program in Molecular and Genetic Epidemiology at the Harvard T.H. Chan School of Public Health. To identify clinically actionable biomarkers, she has led translational and collaborative research on gene regulation in cancer, including studies on germline genetic risk, nutritional genomics, cancer genomics and epigenomics. Her current research is on breast cancer genomics and her future goals are to design a strength training survivorship trial in partnership with the community. Dr. Hazra’s American Cancer Society funded research aims to evaluate the transcriptome and improve stratification of subsequent breast cancer risk among racially diverse DCIS (ductal carcinoma in situ) patients. The completion of the “precision health equity” aims may lead to personalized treatment for all DCIS patients and may prevent DCIS progression to invasive breast cancer. As a Fulbright Specialist candidate in global health, Dr. Hazra aims to improve awareness, early detection of breast cancer, and survivorship for all women.
MPH: University of Texas, Houston
PhD: UT M.D. Anderson Cancer and UT Graduate School of Biomedical Sciences
Full Listing of Publications
- Physical activity before and after cancer diagnosis and mortality risk in three large prospective cohorts October 8, 2024CONCLUSIONS: Remaining active pre- and post-diagnosis and becoming active post-diagnosis may be associated with improvements in cancer survival, however, research is needed across diverse cancer populations.Cami N Christopher
- Improving Cancer Care for Women Seeking Services in the Veterans Health Administration Through the Breast and Gynecological Oncology System of Excellence September 23, 2024Women are the fastest growing population among Veterans and have substantial risk factors that increase their likelihood for developing cancer. To ensure that the Department of Veterans Affairs Veterans Health Administration (VHA) offers the best possible cancer care to women Veterans, it established the Breast and Gynecologic Oncology System of Excellence (BGSoE) in 2021. The […]Megan Shepherd-Banigan
- Summary and Roadmap of Breast Cancer Research in the Veterans Affairs July 9, 2024Women are the largest growing population of Veterans within the U.S. Department of Veterans Affairs (VA) Health Care System. Among women Veterans, breast cancer is the most common malignancy (30% of all cancers), yet little is known about the unique needs of women Veterans with cancer and how to provide them with high quality care. […]Aditi Hazra
- Congressional Expansion of Enhancing Breast Cancer Screening and Care at the Veterans Health Administration May 22, 2024Despite high screening rates, breast cancer disparities persist among women veterans because of occupational risks and barriers to access. Three essential bills recently passed in Congress seek to expand access to breast cancer screenings and cancer care within the Veterans Health Administration. The Making Advances in Mammography and Medical Options for Veterans Act expands screening […]Jenny Wu
- Disparities in Breast Cancer Characteristics Among Syrian Migrants and Jordanian Women in the Jordan Cancer Registry from 2010 to 2016 July 24, 2023No abstractAditi Hazra